SARS‐CoV‐2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with Polycystic Ovary Syndrome (PCOS) and COVID‐19
Alexandra M Huffman(State Street (United States)), Damián G. Romero(University of Mississippi Medical Center), Licy Yanes Cardozo(Jackson Memorial Hospital), Jelina Basnet(University of Mississippi Medical Center), Samar Rezq(University of Mississippi Medical Center)
Cited by 1
Related Papers
Impact of Probiotics and Prebiotics on Gut Microbiome and Hormonal Regulation
|Gastrointestinal Disorders|2024|37
Biomarkers in polycystic ovary syndrome
|Current Opinion in Physiology|2023|21
Thymus algeriensis and Thymus fontanesii exert neuroprotective effect against chronic constriction injury-induced neuropathic pain in rats
|Scientific Reports|2020|20
SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19
|International Journal of Molecular Sciences|2021|20
Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
|International Journal of Molecular Sciences|2021|10